J0589 – Injection, daxibotulinumtoxina-lanm, 1 unit

Long description

Injection, daxibotulinumtoxina-lanm, 1 unit

Short description

Inj daxibotulinumtoxina-lanm

Pricing indicator

51 Drugs

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

O1E Other drugs

ASC

Approved for ambulatory surgical centers

Added

April 1, 2024

Last change

April 1, 2024 – No change

Nearby J codes

• J0578 – Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy
• J0582 – Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg
• J0583 – Injection, bivalirudin, 1 mg
• J0584 – Injection, burosumab-twza 1 mg
• J0585 – Injection, onabotulinumtoxina, 1 unit
• J0586 – Injection, abobotulinumtoxina, 5 units
• J0587 – Injection, rimabotulinumtoxinb, 100 units
• J0588 – Injection, incobotulinumtoxin a, 1 unit
• J0591 – Injection, deoxycholic acid, 1 mg
• J0592 – Injection, buprenorphine hydrochloride, 0.1 mg
• J0593 – Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)
• J0594 – Injection, busulfan, 1 mg
• J0595 – Injection, butorphanol tartrate, 1 mg
• J0596 – Injection, c1 esterase inhibitor (recombinant), ruconest, 10 units
• J0597 – Injection, c-1 esterase inhibitor (human), berinert, 10 units
• J0598 – Injection, c-1 esterase inhibitor (human), cinryze, 10 units